Skip to content

Application of modified score about upper respiratory tract infection in general anesthesia of emergency children

Application of modified score about upper respiratory tract infection in general anesthesia of emergency children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020859
Enrollment
Unknown
Registered
2019-01-21
Start date
2019-01-10
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emergency children with upper respiratory tract infection

Interventions

Intervention group:Salbutamol + Routine treatment
Control group:Routine treatment

Sponsors

Children's Hospital Affiliated to Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
0.5 Years to 7 Years

Inclusion criteria

Inclusion criteria: Selection criteria (participants must meet all of the following requirements before they can be included in the group): (1) Aged 6 months to 7 years male and female; (2) children with mild to moderate upper respiratory tract infection; (3) ASA(American society of anesthesiologists) grade I to II; (4) children who need operation in emergency department; (5) the guardian of the child agreed to participate in the clinical study and signed the informed consent.

Exclusion criteria

Exclusion criteria: (1) severe upper respiratory tract infection diagnosed before operation; (2) pneumonia and lower respiratory tract infection; (3) the operative site involved respiratory tract, polyp of respiratory tract and tumor of respiratory tract; (4) obese children (weight gain over the average of 20% children of the same sex and the same height, the weight of the standard weight children: 6 + months of age from 6 to 12 months * 0.25; age from 2 to 12 years * 2 + 7 or 8); (5) those allergic to the intended use of narcotic drugs; (6) tracheal intubation; (7) obvious history of cardiovascular, respiratory, central nervous system, liver and kidney diseases; (8) taking other experimental drugs or participating in other clinical trials within 1 month before being selected for the study;Anesthesiologists and surgeons did not consider it appropriate to participate in the clinical study.

Design outcomes

Primary

MeasureTime frame
cough;expectoration;breath-holding;laryngospasm;bronchospasm;retrolingual drop;pulse oxygen saturation < 90%;axillary temperature = 38 degree C;

Secondary

MeasureTime frame
heart rate;body temperature;pulse oxygen saturation;airway pressure;end-expiratory partial pressure of carbon dioxide;anesthesia time;operation time;length of hospital stay;prognosis;

Countries

China

Contacts

Public ContactYang Jin

Children's Hospital Affiliated to Nanjing Medical University

75442942@qq.com+86 13645180370

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026